Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
It was reported that the patient was experiencing painful stimulation at the neck site.Therefore, the patient underwent a revision surgery to correct this pain.During this surgery, liquid was observed inside the lead sheath resulting in no devices being exchanged during the surgery.The device was left in place and turned off.No known relevant surgical intervention has occurred to date.No other relevant information has been received to date.
|